Ausgabe 2/2022
Inhalt (15 Artikel)
Minimally Invasive Pancreatoduodenectomy: Contemporary Practice, Evidence, and Knowledge Gaps
Jacob Ghotbi, Mushegh Sahakyan, Kjetil Søreide, Åsmund Avdem Fretland, Bård Røsok, Tore Tholfsen, Anne Waage, Bjørn Edwin, Knut Jørgen Labori, Sheraz Yaqub, Dyre Kleive
Basal Cell Carcinoma: A Narrative Review on Contemporary Diagnosis and Management
Piyu Parth Naik, Munaf B. Desai
The Implementation of Minimally Invasive Surgery in the Treatment of Esophageal Cancer: A Step Toward Better Outcomes?
Tania Triantafyllou, Pieter van der Sluis, Richard Skipworth, Bas P. L. Wijnhoven
Pegfilgrastim Biosimilars in US Supportive Oncology: A Narrative Review of Administration Options and Economic Considerations to Maximize Patient Benefit
Sophia Z. Humphreys, Robert B. Geller, Paul Walden
The Anticancer Effect of Metformin Combined with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer Patients with or Without Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis
Qiman Zhang, Jin Zheng, Wen Wang, Elyse M. Cornett, Alan David Kaye, Ivan Urits, Omar Viswanath, Fei-Long Wei
The Effect of Irisin on Proliferation, Apoptosis, and Expression of Metastasis Markers in Prostate Cancer Cell Lines
Atiye Saeedi Sadr, Hassan Ehteram, Elahe Seyed Hosseini, Marziyeh Alizadeh Zarei, Hassan Hassani Bafrani, Hamed Haddad Kashani
Correction to: The Effect of Irisin on Proliferation, Apoptosis, and Expression of Metastasis Markers in Prostate Cancer Cell Lines
Atiye Saeedi Sadr, Hassan Ehteram, Elahe Seyed Hosseini, Marziyeh Alizadeh Zarei, Hassan Hassani Bafrani, Hamed Haddad Kashani
Cost-Effectiveness of PD-L1 Testing in Non-Small Cell Lung Cancer (NSCLC) Using In Vitro Diagnostic (IVD) Versus Laboratory-Developed Test (LDT)
Jason T. Hurwitz, Shannon Vaffis, Amy J. Grizzle, Søren Nielsen, Andrew Dodson, Suzanne Parry
Healthcare Costs of Multiple Myeloma Patients with Four or More Prior Lines of Therapy, Including Triple-Class Exposure in the United States
Sundar Jagannath, Nedra Joseph, Jinghua He, Concetta Crivera, Alex Z. Fu, Ashraf Garrett, Nina Shah
Patient, Family Member and Physician Perspectives and Experiences with AML Treatment Decision-Making
Thomas W. LeBlanc, Nigel H. Russell, Loriana Hernandez-Aldama, Charlotte Panter, Timothy J. Bell, Verna Welch, Diana Merino Vega, Louise O’Hara, Julia Stein, Melissa Barclay, Francois Peloquin, Andrew Brown, Jasmine Healy, Lucy Morgan, Adam Gater, Ryan Hohman, Karim Amer, Dawn Maze, Roland B. Walter
Breast Cancer with Low Recurrence Score on Oncotype DX©: Interplay Between Early Recurrence, Lobular Histology and BRCA Mutation
Yonaton Zarbiv, Yael Berner Wygoda, Albert Grinshpun, Tamar Hamburger, Tamar Sella, Shani Breuer, Ofra Maimon, Yakir Rottenberg, Tamar Peretz, Luna Kadouri
Expression and Prognostic Significance of Stem Cell Marker CD133 in Survival Rate of Patients with Colon Cancer
Hassan Ehteram, Fatemeh Aslanbeigi, Ebrahim Ghoochani Khorasani, Mohammad Tolouee, Hamed Haddad Kashani
Lanreotide Depot to Treat Gastroenteropancreatic Neuroendocrine Tumors in a US Community Oncology Setting: A Prospective, Observational Study
Scott Paulson, David Ray, Sharan Aranha, Amy Scales, Yunfei Wang, Eric Liu
The Role of Electronic Patient-Reported Outcome Measures in Assessing Smoking Status and Cessation for Patients with Lung Cancer
James Convill, Fiona Blackhall, Janelle Yorke, Corrine Faivre-Finn, Fabio Gomes
MRI Grading Scale Predicts Ambulatory Function After Radiotherapy for Metastatic Spinal Cord Compression: A Prospective Single-Institution Observational Study
Natsuko Yano, Takashi Ono, Tomoto Suzuki, Yasuhiro Sugai, Masayoshi Yamada, Shohei Kawashiro, Mayumi Harada, Hiroko Akamatsu, Yasuhito Hagiwara, Mayumi Ichikawa, Hiraku Sato, Michiaki Takagi, Masafumi Kanoto, Kenji Nemoto